Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression Free Survival for Patients with Chronic Myelomonocytic Leukemia

The treatment of patients with chronic myelomonocytic leukemia (CMML) with transplant has not been optimized. We retrospectively reviewed the data for 83 consecutive patients with CMML (47 with CMML-1/2 and 36 with CMML progressed to acute myeloid leukemia) who received an allogeneic stem cell trans...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Biol Blood Marrow Transplant
Päätekijät: Kongtim, Piyanuch, Popat, Uday, Jimenez, Antonio, Gaballa, Sameh, Fakih, Riad El, Rondon, Gabriela, Chen, Julianne, Bueso-Ramos, Carlos, Borthakur, Gautam, Pemmaraju, Naveen, Garcia-Manero, Guillermo, Kantarjian, Hagop, Alousi, Amin, Hosing, Chitra, Anderlini, Paolo, Khouri, Issa F., Kebriaei, Partow, Andersson, Borje S., Oran, Betul, Rezvani, Katayoun, Marin, David, Shpall, Elizabeth J., Champlin, Richard E., Ciurea, Stefan O.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2015
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4892364/
https://ncbi.nlm.nih.gov/pubmed/26343946
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2015.08.031
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia